These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 37373089)
1. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra. Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869 [TBL] [Abstract][Full Text] [Related]
3. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse. Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice. Shi X; Chen YH; Liu H; Qu HD Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986 [TBL] [Abstract][Full Text] [Related]
5. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease. Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146 [TBL] [Abstract][Full Text] [Related]
6. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease. Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693 [TBL] [Abstract][Full Text] [Related]
7. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway. Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576 [TBL] [Abstract][Full Text] [Related]
8. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. Rai SN; Yadav SK; Singh D; Singh SP J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective potential of plant derived parenchymal stem cells extract on environmental and genetic models of Parkinson disease through attenuation of oxidative stress and neuroinflammation. Ishola IO; Oloyo AK; Olubodun-Obadun TG; Godswill OD; Omilabu SA; Adeyemi OO Metab Brain Dis; 2023 Feb; 38(2):557-571. PubMed ID: 36401682 [TBL] [Abstract][Full Text] [Related]
10. Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway. Wang K; Han C; Yang J; Xu W; Wang L; Li H; Wang Y PLoS One; 2024; 19(7):e0307012. PubMed ID: 39042624 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease. Pariyar R; Bastola T; Lee DH; Seo J Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503 [TBL] [Abstract][Full Text] [Related]
12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503 [TBL] [Abstract][Full Text] [Related]
13. Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson's disease by inhibiting oxidative stress and neuroinflammation. Chen M; He X; Fan Y; Xia L; Dong Z Mol Biol Rep; 2024 Aug; 51(1):908. PubMed ID: 39141244 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Nicotinamide against MPTP-Induced Parkinson's Disease in Mice: Impact on Oxidative Stress, Neuroinflammation, Nrf2/HO-1 and TLR4 Signaling Pathways. Rehman IU; Khan A; Ahmad R; Choe K; Park HY; Lee HJ; Atiq A; Park J; Hahm JR; Kim MO Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428497 [TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958 [TBL] [Abstract][Full Text] [Related]
16. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response. Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway. Ren Y; Ye D; Ding Y; Wei N Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596 [No Abstract] [Full Text] [Related]
18. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease. Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system. Guo Z; Xu S; Du N; Liu J; Huang Y; Han M Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]